OC
BIND

Oppenheimer & Co’s BIND THERAPEUTICS INC BIND Stock Holding History

Oppenheimer & Co’s Portfolio BIND Stock Details BIND Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q4 		– Sell
-10,500
Closed -$46K – 1459
2015
Q3 		$46K Hold
10,500
– – ﹤0.01% 1308
2015
Q2 		$59K Buy
+10,500
New +$65.1K ﹤0.01% 1433

Other funds holding BIND

PVMCV
Polaris Venture Management Co V Boston, Massachusetts $14.1M AUM 121.41% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Principal Financial Group
Principal Financial Group Des Moines, Iowa $187B AUM 18.48% 1-Year Est. Return
RPAM
Rhenman & Partners Asset Management Stockholm, Sweden $810M AUM 30.2% 1-Year Est. Return
BCM
Bridgeway Capital Management Houston, Texas $4.97B AUM 44.96% 1-Year Est. Return
CS
Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
SIM
Spark Investment Management New York $41.6M AUM 80.97% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

Oppenheimer & Co's BIND Position: Q4 2015 in Review

Oppenheimer & Co sold out of BIND THERAPEUTICS INC (BIND) in Q4 2015, closing a stake of 10,500 shares — an estimated $46K sold.

Oppenheimer & Co first reported a position in BIND in Q2 2015 and held it in 2 quarters. The position peaked at $59K in Q2 2015. 38 funds tracked by Wall St. Rank hold BIND as of Q4 2015.

  • Oppenheimer & Co reported no remaining BIND THERAPEUTICS INC position as of Q4 2015 after selling out during the quarter.
  • Oppenheimer & Co sold 10,500 BIND THERAPEUTICS INC shares in Q4 2015, an estimated $46K.
  • Oppenheimer & Co first reported a position in BIND THERAPEUTICS INC in Q2 2015 and held it in 2 quarters.
  • Oppenheimer & Co's BIND THERAPEUTICS INC position peaked at $59K in Q2 2015.
  • 38 funds tracked by Wall St. Rank held BIND THERAPEUTICS INC as of Q4 2015.

Based on Oppenheimer & Co's 13F filing for Q4 2015, filed 3 Feb 2016.